The effect of heparin on parenteral lipid metabolism and tolerance in newborns

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

ISRCTN

Registry ID

ISRCTN32517537

Enrollment

140

Registered

2003-09-12

Start date

2000-09-01

Completion date

Unknown

Last updated

2015-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Neonatal Diseases: Lipid metabolism Neonatal Diseases

Interventions

1. Parenteral nutrition with heparin 2. Parenteral nutrition without heparin Heparin is commonly added to the infusions of neonatal patients, to prevent line blockage. This study is to determine whet

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Not provided at time of registration

Exclusion criteria

Exclusion criteria: Not provided at time of registration

Design outcomes

Primary

Measure	Time frame
Not provided at time of registration	—

Secondary

Measure	Time frame
Not provided at time of registration	—

Countries

United Kingdom

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026